Episomal Vectors

Primary and Stem Cells: Gene Transfer Technologies and Applications

Volumn , Issue , 2011, Pages 49-83

  Yu, Junying ^a  

^a Cellular Dynamics International Inc   (United States)

Author keywords

Episomal reprogramming; Episomal vectors; OriP EBNA 1 based episomal approach

Indexed keywords

EID: 84886034255     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118147177.ch4     Document Type: Chapter

References (189)

1. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193.
2. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., Cavazzana-Calvo, M., et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
3. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415-419.
4. Newlon, C.S. and Theis, J.F. (1993) The structure and function of yeast ARS elements. Curr. Opin. Genet. Dev., 3, 752-758.
5. Gilbert, D.M. (2004) In search of the holy replicator. Nat. Rev. Mol. Cell Biol., 5, 848-855.
6. Murray, A.W. and Szostak, J.W. (1983) Construction of artificial chromosomes in yeast. Nature, 305, 189-193.
7. Harrington, J.J., Van Bokkelen, G., Mays, R.W., Gustashaw, K. andWillard, H. F. (1997) Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nat. Genet., 15, 345-355.
8. Wade-Martins, R., Frampton, J. and James, M.R. (1999) Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res., 27, 1674-1682.
9. Kitagawa, K. and Hieter, P. (2001) Evolutionary conservation between budding yeast and human kinetochores. Nat. Rev. Mol. Cell Biol., 2, 678-687.
10. Henikoff, S., Ahmad, K. and Malik, H.S. (2001) The centromere paradox: stable inheritance with rapidly evolving DNA. Science, 293, 1098-1102.
11. Jabs, E.W. and Persico, M.G. (1987) Characterization of human centromeric regions of specific chromosomes by means of alphoid DNA sequences. Am. J. Hum. Genet., 41, 374-390.
12. Willard, H.F. (1990) Centromeres of mammalian chromosomes. Trends Genet., 6, 410-416.
13. du Sart, D., Cancilla, M.R., Earle, E., Mao, J.I., Saffery, R., Tainton, K.M., Kalitsis, P., Martyn, J., Barry, A.E. and Choo, K.H. (1997) A functional neocentromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nat. Genet., 16, 144-153.
14. Masumoto, H., Ikeno, M., Nakano, M., Okazaki, T., Grimes, B., Cooke, H. and Suzuki, N. (1998) Assay of centromere function using a human artificial chromosome. Chromosoma, 107, 406-416.
15. Ohzeki, J., Nakano, M., Okada, T. and Masumoto, H. (2002) CENP-B box is required for de novo centromere chromatin assembly on human alphoidDNA. J. Cell Biol., 159, 765-775.
16. Osterhage, J.L. and Friedman, K.L. (2009) Chromosome end maintenance by telomerase. J. Biol. Chem., 284, 16061-16065.
17. Ikeno, M., Grimes, B., Okazaki, T., Nakano, M., Saitoh, K., Hoshino, H., McGill, N.I., Cooke, H. and Masumoto, H. (1998) Construction of YAC-based mammalian artificial chromosomes. Nat. Biotechnol., 16, 431-439.
18. Ebersole, T.A., Ross, A., Clark, E., McGill, N., Schindelhauer, D., Cooke, H. and Grimes, B. (2000) Mammalian artificial chromosome formation from circular alphoid input DNA does not require telomere repeats. Hum. Mol. Genet., 9, 1623-1631.
19. Farr, C.J., Bayne, R.A., Kipling, D., Mills, W., Critcher, R. and Cooke, H.J. (1995) Generation of a human X-derived minichromosome using telomereassociated chromosome fragmentation. EMBO J., 14, 5444-5454.
20. Mills, W., Critcher, R., Lee, C. and Farr, C.J. (1999) Generation of an approximately 2.4 Mb human X centromere-based minichromosome by targeted telomere-associated chromosome fragmentation in DT40. Hum. Mol. Genet., 8, 751-761.
21. Grimes, B.R., Schindelhauer, D., McGill, N.I., Ross, A., Ebersole, T.A. and Cooke, H.J. (2001) Stable gene expression from a mammalian artificial chromosome. EMBO Rep., 2, 910-914.
22. Kuroiwa,Y., Tomizuka, K., Shinohara, T., Kazuki,Y.,Yoshida, H., Ohguma, A., Yamamoto, T., Tanaka, S., Oshimura, M. and Ishida, I. (2000) Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat. Biotechnol., 18, 1086-1090.
23. Moralli, D., Vagnarelli, P., Bensi, M., De Carli, L. and Raimondi, E. (2001) Insertion of a loxP site in a size-reduced human accessory chromosome. Cytogenet. Cell Genet., 94, 113-120.
24. Kotzamanis, G., Cheung, W., Abdulrazzak, H., Perez-Luz, S., Howe, S., Cooke, H. and Huxley, C. (2005) Construction of human artificial chromosome vectors by recombineering. Gene, 351, 29-38.
25. Auriche, C., Carpani, D., Conese, M., Caci, E., Zegarra-Moran, O., Donini, P. and Ascenzioni, F. (2002) Functional human CFTR produced by a stable minichromosome. EMBO Rep., 3, 862-868.
26. Kuroiwa, Y., Yoshida, H., Ohshima, T., Shinohara, T., Ohguma, A., Kazuki, Y., Oshimura, M., Ishida, I. and Tomizuka, K. (2002) The use of chromosomebased vectors for animal transgenesis. Gene Ther., 9, 708-712.
27. Perry, A.C., Rothman, A., de Las Heras, J.I., Feinstein, P., Mombaerts, P., Cooke, H.J. andWakayama, T. (2001) Efficient metaphase II transgenesis with different transgene archetypes. Nat. Biotechnol., 19, 1071-1073.
28. Heng, H.H., Goetze, S.,Ye, C.J., Liu, G., Stevens, J.B., Bremer, S.W.,Wykes, S. M., Bode, J. and Krawetz, S.A. (2004) Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J. Cell Sci., 117, 999-1008.
29. Brylawski, B.P., Tsongalis, G.J., Cordeiro-Stone, M., May,W.T., Comeau, L.D. and Kaufman, D.G. (1993) Association of putative origins of replication with the nuclear matrix in normal human fibroblasts. Cancer Res., 53, 3865-3868.
30. Dijkwel, P.A. and Hamlin, J.L. (1988) Matrix attachment regions are positioned near replication initiation sites, genes, and an interamplicon junction in the amplified dihydrofolate reductase domain of Chinese hamster ovary cells. Mol. Cell. Biol., 8, 5398-5409.
31. Vogelstein, B., Pardoll, D.M. and Coffey, D.S. (1980) Supercoiled loops and eucaryotic DNA replicaton. Cell, 22, 79-85.
32. Piechaczek, C., Fetzer, C., Baiker, A., Bode, J. and Lipps, H.J. (1999) Avector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res., 27, 426-428.
33. Schaarschmidt, D., Baltin, J., Stehle, I.M., Lipps, H.J. and Knippers, R. (2004) An episomal mammalian replicon: sequence-independent binding of the origin recognition complex. EMBO J., 23, 191-201.
34. Baiker, A., Maercker, C., Piechaczek, C., Schmidt, S.B., Bode, J., Benham, C. and Lipps, H.J. (2000) Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol., 2, 182-184.
35. Jenke, B.H., Fetzer, C.P., Stehle, I.M., Jonsson, F., Fackelmayer, F.O., Conradt, H., Bode, J. and Lipps, H.J. (2002) An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Rep., 3, 349-354.
36. Jenke, A.C., Stehle, I.M., Herrmann, F., Eisenberger, T., Baiker, A., Bode, J., Fackelmayer, F.O. and Lipps, H.J. (2004) Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc. Natl. Acad. Sci. USA, 101, 11322-11327.
37. Stehle, I.M., Scinteie, M.F., Baiker, A., Jenke, A.C. and Lipps, H.J. (2003) Exploiting a minimal system to study the epigenetic control ofDNAreplication: the interplay between transcription and replication. Chromosome Res., 11, 413-421.
38. Bode, J., Benham, C., Knopp, A. and Mielke, C. (2000) Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit. Rev. Eukaryot. Gene Expr., 10, 73-90.
39. Jenke, A.C., Eisenberger, T., Baiker, A., Stehle, I.M.,Wirth, S. and Lipps, H.J. (2005) The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA. Hum. Gene Ther., 16, 533-539.
40. Sotirova, V.N., Calciano, M.A., Krueger, W. and Lalande, M. (2006) Inclusion of a matrix-attached region in a 7SK pol III vector increases the efficiency of shRNA-mediated gene silencing in embryonic carcinoma cells. Plasmid, 55, 216-226.
41. Manzini, S.,Vargiolu, A., Stehle, I.M., Bacci, M.L., Cerrito, M.G., Giovannoni, R., Zannoni, A., Bianco, M.R., Forni, M., Donini, P., et al. (2006) Genetically modified pigs produced with a nonviral episomal vector. Proc. Natl. Acad. Sci. USA, 103, 17672-17677.
42. Bergsma, D.J., Olive, D.M., Hartzell, S.W. and Subramanian, K.N. (1982) Territorial limits and functional anatomy of the simian virus 40 replication origin. Proc. Natl. Acad. Sci. USA, 79, 381-385.
43. Blow, J.J. and Dutta,A. (2005) Preventing re-replication of chromosomalDNA. Nat. Rev. Mol. Cell Biol., 6, 476-486.
44. DePamphilis, M.L. (2003) The 'ORC cycle': a novel pathway for regulating eukaryotic DNA replication. Gene, 310, 1-15.
45. Ohta, S., Tatsumi, Y., Fujita, M., Tsurimoto, T. and Obuse, C. (2003) The ORC1 cycle in human cells: II. Dynamic changes in the human ORC complex during the cell cycle. J. Biol. Chem., 278, 41535-41540.
46. Reed, S.I., Ferguson, J., Davis, R.W. and Stark, G.R. (1975) T antigen binds to simian virus 40DNAat the origin of replication. Proc. Natl. Acad. Sci. USA, 72, 1605-1609.
47. Myers, R.M. and Tjian, R. (1980) Construction and analysis of simian virus 40 origins defective in tumor antigen binding and DNA replication. Proc. Natl. Acad. Sci. USA, 77, 6491-6495.
48. Milanesi, G., Barbanti-Brodano, G., Negrini, M., Lee, D., Corallini, A., Caputo, A., Grossi, M.P. and Ricciardi, R.P. (1984) BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli. Mol. Cell. Biol., 4, 1551-1560.
49. Gardner, S.D., Field, A.M., Coleman, D.V. and Hulme, B. (1971) New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet, 1, 1253-1257.
50. Egli, A., Infanti, L., Dumoulin, A., Buser, A., Samaridis, J., Stebler, C., Gosert, R. and Hirsch, H.H. (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis., 199, 837-846.
51. Dhar, R., Lai, C.J. and Khoury, G. (1978) Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell, 13, 345-358.
52. Seif, I., Khoury, G. and Dhar, R. (1979) The genome of human papovavirus BKV. Cell, 18, 963-977.
53. Caputo, A., Barbanti-Brodano, G., Wang, E. and Ricciardi, R.P. (1986) Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens. Virology, 152, 459-465.
54. Lai, C.J., Goldman, N.D. and Khoury, G. (1979) Functional similarity between the early antigens of simian virus 40 and human papovavirus BK. J. Virol., 30, 141-147.
55. Major, E.O. and Matsumura, P. (1984) Human embryonic kidney cells: stable transformation with an origin-defective simian virus 40 DNA and use as hosts for human papovavirus replication. Mol. Cell. Biol., 4, 379-382.
56. Ryder, K., DeLucia, A.L. and Tegtmeyer, P. (1983) Binding of SV40 a protein to the BK virus origin of DNA replication. Virology, 129, 239-245.
57. Deyerle, K.L., Sajjadi, F.G. and Subramani, S. (1989) Analysis of origin of DNA replication of human papovavirus BK. J. Virol., 63, 356-365.
58. Grossi, M.P., Caputo, A., Rimessi, P., Chiccoli, L., Balboni, P.G. and Barbanti- Brodano, G. (1988) New BK virus episomal vector for complementary DNA expression in human cells. Arch. Virol., 102, 275-283.
59. Prives, C., Murakami, Y., Kern, F.G., Folk, W., Basilico, C. and Hurwitz, J. (1987) DNA sequence requirements for replication of polyomavirus DNA in vivo and in vitro. Mol. Cell. Biol., 7, 3694-3704.
60. Caputo, A., Barbanti-Brodano, G., Reschiglian, P., Gianni, M., Mottes, M., Miranda, P., Milanesi, G., Knowles, B.B. and Ricciardi, R.P. (1988) Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector. J. Gen. Virol., 69 (Pt. 2), 459-466.
61. Cooper, M.J. and Miron, S. (1993) Efficient episomal expression vector for human transitional carcinoma cells. Hum. Gene Ther., 4, 557-566.
62. Grossi, M.P., Caputo, A., Paolini, L., Balboni, P.G., Gerna, G., Pagnani, M., Corallini, A. and Barbanti-Brodano, G. (1988) Factors affecting amplification of BKvirus episomal vectors inhuman cells. Brief report. Arch. Virol., 99, 249-259.
63. Harris, K.F., Christensen, J.B. and Imperiale, M.J. (1996) BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J. Virol., 70, 2378-2386.
64. Nakshatri, H., Pater, M.M. and Pater, A. (1988) Functional role of BK virus tumor antigens in transformation. J. Virol., 62, 4613-4621.
65. Ray, F.A., Peabody, D.S., Cooper, J.L., Cram, L.S. and Kraemer, P.M. (1990) SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J. Cell. Biochem., 42, 13-31.
66. Trabanelli, C., Corallini, A.,Gruppioni, R., Sensi, A., Bonfatti, A., Campioni, D., Merlin, M., Calza, N., Possati, L. and Barbanti-Brodano, G. (1998) Chromosomal aberrations induced byBKvirus Tantigen in human fibroblasts. Virology, 243, 492-496.
67. Van Craenenbroeck, K., Vanhoenacker, P., Duchau, H. and Haegeman, G. (2000) Molecular integrity and usefulness of episomal expression vectors derived from BK and Epstein-Barr virus. Gene, 253, 293-301.
68. Piirsoo, M., Ustav, E., Mandel, T., Stenlund, A. and Ustav, M. (1996) Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J., 15, 1-11.
69. Mansky, K.C., Batiza, A. and Lambert, P.F. (1997) Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions. J. Virol., 71, 7600-7608.
70. Seo, Y.S., Muller, F., Lusky, M. and Hurwitz, J. (1993) Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc. Natl. Acad. Sci. USA, 90, 702-706.
71. Ilves, I., Kivi, S. and Ustav, M. (1999) Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites. J. Virol., 73, 4404-4412.
72. Ilves, I., Kadaja, M. and Ustav,M. (2003) Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res., 96, 75-84.
73. Gilbert, D.M. and Cohen, S.N. (1987) Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell, 50, 59-68.
74. Ohe, Y., Zhao, D., Saijo, N. and Podack, E.R. (1995) Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum. Gene Ther., 6, 325-333.
75. Tammur, J., Sibul, H., Ustav, E., Ustav, M. and Metspalu, A. (2002) A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficientCHO-ldlA7 cell line.BMCMol. Biol., 3, 5.
76. Sawamura, D., Meng, X., Ina, S., Kon, A., Tamai, K., Ohe, Y. and Hashimoto, I. (2000) Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy. J. Dermatol. Sci., 23, 111-116.
77. Waldenstrom, M., Schenstrom, K., Sollerbrant, K. and Hansson, L. (1992) Replication of bovine papillomavirus vectors in murine cells. Gene, 120, 175-181.
78. Klein, G. (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77, 791-793.
79. Sakajiri, S., Mori, K., Isobe, Y., Kawamata, N. and Oshimi, K. (2002) Epstein-Barr virus-associated T-cell acute lymphoblastic leukaemia. Br. J. Haematol., 117, 127-129.
80. Sugden, B. (1982) Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev. Infect. Dis., 4, 1048-1061.
81. Delecluse, H.J., Bartnizke, S., Hammerschmidt, W., Bullerdiek, J. and Bornkamm, G.W. (1993) Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J. Virol., 67, 1292-1299.
82. Hurley, E.A., Agger, S., McNeil, J.A., Lawrence, J.B., Calendar, A., Lenoir, G. and Thorley-Lawson, D.A. (1991) When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J. Virol., 65, 1245-1254.
83. Hurley, E.A., Klaman, L.D., Agger, S., Lawrence, J.B. and Thorley-Lawson, D. A. (1991) The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J. Virol., 65, 3958-3963.
84. Koliais, S., Bjursell, G., Adams, A., Lindahl, T. and Klein, G. (1978) State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line. J. Natl. Cancer Inst., 60, 991-994.
85. Yates, J., Warren, N., Reisman, D. and Sugden, B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA, 81, 3806-3810.
86. Yates, J.L., Warren, N. and Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.
87. Reisman, D., Yates, J. and Sugden, B. (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol., 5, 1822-1832.
88. Rawlins, D.R.,Milman, G., Hayward, S.D. and Hayward, G.S. (1985) Sequencespecific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell, 42, 859-868.
89. Bashaw, J.M. andYates, J.L. (2001) Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J. Virol., 75, 10603-10611.
90. Yates, J.L., Camiolo, S.M. and Bashaw, J.M. (2000) The minimal replicator of Epstein-Barr virus oriP. J. Virol., 74, 4512-4522.
91. Reisman, D. and Sugden, B. (1986) trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol., 6, 3838-3846.
92. Chittenden, T., Lupton, S. and Levine, A.J. (1989) Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication. J. Virol., 63, 3016-3025.
93. Wysokenski, D.A. and Yates, J.L. (1989) Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol., 63, 2657-2666.
94. Ambinder, R.F., Mullen, M.A., Chang, Y.N., Hayward, G.S. and Hayward, S.D. (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol., 65, 1466-1478.
95. Chen, M.R., Middeldorp, J.M. and Hayward, S.D. (1993) Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol., 67, 4875-4885.
96. Inoue, N., Harada, S., Honma, T., Kitamura, T. and Yanagi, K. (1991) The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Virology, 182, 84-93.
97. Polvino-Bodnar,M. and Schaffer, P.A. (1992) DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication. Virology, 187, 591-603.
98. Kitamura, R., Sekimoto, T., Ito, S., Harada, S., Yamagata, H., Masai, H., Yoneda, Y. and Yanagi, K. (2006) Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and downregulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential. J. Virol., 80, 1979-1991.
99. Kishida, T., Asada, H., Kubo, K., Sato, Y.T., Shin-Ya, M., Imanishi, J., Yoshikawa, K. and Mazda, O. (2008) Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells. J. Biotechnol., 133, 201-207.
100. Middleton, T. and Sugden, B. (1994) Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol., 68, 4067-4071.
101. Frappier, L. and O'Donnell, M. (1991) Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA, 88, 10875-10879.
102. Su,W., Middleton, T., Sugden, B. and Echols, H. (1991) DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl. Acad. Sci. USA, 88, 10870-10874.
103. Mackey, D., Middleton, T. and Sugden, B. (1995) Multiple regions within EBNA1 can link DNAs. J. Virol., 69, 6199-6208.
104. Mackey, D. and Sugden, B. (1999) The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell. Biol., 19, 3349-3359.
105. Marechal,V., Dehee, A., Chikhi-Brachet, R., Piolot, T., Coppey-Moisan, M. and Nicolas, J.C. (1999) Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol., 73, 4385-4392.
106. Sears, J., Ujihara, M., Wong, S., Ott, C., Middeldorp, J. and Aiyar, A. (2004) The amino terminus of Epstein-BarrVirus (EBV) nuclear antigen 1 containsAT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol., 78, 11487-11505.
107. Wendelburg, B.J. and Vos, J.M. (1998) An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells. Gene Ther., 5, 1389-1399.
108. Belt, P.B., Groeneveld, H., Teubel, W.J., van de Putte, P. and Backendorf, C. (1989) Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells. Gene, 84, 407-417.
109. Sternas, L., Middleton, T. and Sugden, B. (1990) The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J. Virol., 64, 2407-2410.
110. Yates, J.L. and Guan, N. (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol., 65, 483-488.
111. Frappier, L. and O'Donnell, M. (1991) Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J. Biol. Chem., 266, 7819-7826.
112. Chaudhuri, B., Xu, H., Todorov, I., Dutta,A. andYates, J.L. (2001) HumanDNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA, 98, 10085-10089.
113. Schepers, A., Ritzi, M., Bousset, K., Kremmer, E., Yates, J.L., Harwood, J., Diffley, J.F. andHammerschmidt,W. (2001) Human origin recognition complex binds to the region of the latent origin ofDNAreplication of Epstein-Barr virus. EMBO J., 20, 4588-4602.
114. Aiyar, A., Tyree, C. and Sugden, B. (1998) The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNAsynthesis by the cell and a viral maintenance element. EMBO J., 17, 6394-6403.
115. Kapoor, P. and Frappier, L. (2003) EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J. Virol., 77, 6946-6956.
116. Nayyar, V.K., Shire, K. and Frappier, L. (2009) Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J. Cell Sci., 122, 4341-4350.
117. Kirchmaier, A.L. and Sugden, B. (1998) Rep*: a viral element that can partially replace the origin of plasmid DNAsynthesis of Epstein-Barr virus. J. Virol., 72, 4657-4666.
118. Wang, J., Lindner, S.E., Leight, E.R. and Sugden, B. (2006) Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol. Cell. Biol., 26, 1124-1134.
119. Krysan, P.J., Haase, S.B. and Calos, M.P. (1989) Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol., 9, 1026-1033.
120. Kanda, T., Otter, M. and Wahl, G.M. (2001) Coupling of mitotic chromosome tethering and replication competence in Epstein-Barr virus-based plasmids. Mol. Cell. Biol., 21, 3576-3588.
121. Lindner, S.E., Zeller, K., Schepers, A. and Sugden, B. (2008) The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. J. Virol., 82, 5693-5702.
122. Deng, Z., Atanasiu, C., Burg, J.S., Broccoli, D. and Lieberman, P.M. (2003) Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J. Virol., 77, 11992-12001.
123. Deng, Z., Lezina, L., Chen, C.J., Shtivelband, S., So, W. and Lieberman, P.M. (2002) Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol. Cell, 9, 493-503.
124. Hung, S.C., Kang, M.S. and Kieff, E. (2001) Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome- binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. USA, 98, 1865-1870.
125. Hauer, C.A., Getty, R.R. and Tykocinski, M.L. (1989) Epstein-Barr virus episome-based promoter function in human myeloid cells. Nucleic Acids Res., 17, 1989-2003.
126. Lei, D.C., Kunzelmann, K., Koslowsky, T., Yezzi, M.J., Escobar, L.C., Xu, Z., Ellison, A.R., Rommens, J.M., Tsui, L.C., Tykocinski, M., et al. (1996) Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther., 3, 427-436.
127. Min, K.A., Oh, S.T., Yoon, K.H., Kim, C.K. and Lee, S.K. (2003) Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector. Biochem. Biophys. Res. Commun., 305, 108-115.
128. Einav, Y., Shistik, E., Shenfeld, M., Simons, A.H., Melton, D.W. and Canaani, D. (2003) Replication and episomal maintenance of Epstein-Barr virus-based vectors in mouse embryonal fibroblasts enable synthetic lethality screens. Mol. Cancer Ther., 2, 1121-1128.
129. Mizuguchi, H., Hosono, T. and Hayakawa, T. (2000) Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells. FEBS Lett., 472, 173-178.
130. Black, J. andVos, J.M. (2002) Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts. Gene Ther., 9, 1447-1454.
131. Krysan, P.J. and Calos, M.P. (1993) Epstein-Barr virus-based vectors that replicate in rodent cells. Gene, 136, 137-143.
132. Habel, M.E., Drouin, M. and Jung, D. (2004) Maintenance of Epstein-Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2. Biochem. Cell Biol., 82, 375-380.
133. Bornkamm, G.W., Berens, C., Kuklik-Roos, C., Bechet, J.M., Laux, G., Bachl, J., Korndoerfer, M., Schlee, M., Holzel, M., Malamoussi, A., et al. (2005) Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res., 33, e137.
134. Kunaparaju, R., Liao, M. and Sunstrom, N.A. (2005) Epi-CHO, an episomal expression system for recombinant protein production in CHO cells. Biotechnol. Bioeng., 91, 670-677.
135. Mucke, S., Polack, A., Pawlita, M., Zehnpfennig, D., Massoudi, N., Bohlen, H., Doerfler, W., Bornkamm, G., Diehl, V. and Wolf, J. (1997) Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells. Gene Ther., 4, 82-92.
136. Satoh, E., Hirai, H., Inaba, T., Shimazaki, C., Nakagawa, M., Imanishi, J. and Mazda, O. (1998) Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors. FEBS Lett., 441, 39-42.
137. Van Craenenbroeck, K., Vanhoenacker, P., Roman, I. and Haegeman, G. (2003) Orientation-dependent gene expression with Epstein-Barr virus-derived vectors. FEBS Lett., 555, 489-494.
138. Kinsella, T.M. and Nolan, G.P. (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther., 7, 1405-1413.
139. Ren, C., Zhao, M., Yang, X., Li, D., Jiang, X., Wang, L., Shan, W., Yang, H., Zhou, L., Zhou, W., et al. (2006) Establishment and applications of Epstein-Barr virus-based episomal vectors in human embryonic stem cells. Stem Cells, 24, 1338-1347.
140. Thyagarajan, B., Scheyhing, K., Xue, H., Fontes, A., Chesnut, J., Rao, M. and Lakshmipathy, U. (2009) A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells. Regen. Med. 4, 239-250.
141. Huertas, D., Howe, S., McGuigan, A. and Huxley, C. (2000) Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells. Hum. Mol. Genet., 9, 617-629.
142. Magin-Lachmann, C., Kotzamanis, G., D'Aiuto, L.,Wagner, E. and Huxley, C. (2003) Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA- 1-new vectors for in vitro and in vivo delivery. BMC Biotechnol., 3, 2.
143. Simpson, K. and Huxley, C. (1996) A shuttle system for transfer of YACs between yeast and mammalian cells. Nucleic Acids Res., 24, 4693-4699.
144. Simpson, K., McGuigan, A. and Huxley, C. (1996) Stable episomal maintenance of yeast artificial chromosomes in human cells. Mol. Cell. Biol., 16, 5117-5126.
145. Sun, T.Q., Fernstermacher, D.A. andVos, J.M. (1994) Human artificial episomal chromosomes for cloning large DNA fragments in human cells. Nat. Genet., 8, 33-41.
146. Wade-Martins, R., White, R.E., Kimura, H., Cook, P.R. and James, M.R. (2000) Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat. Biotechnol., 18, 1311-1314.
147. Westphal, E.M., Sierakowska, H., Livanos, E., Kole, R. and Vos, J.M. (1998) A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation. Hum. Gene Ther., 9, 1863-1873.
148. Wolfgang, M.J., Marshall, V.S., Eisele, S.G., Schotzko, M.L., Thomson, J.A. and Golos, T.G. (2002) Efficient method for expressing transgenes in nonhuman primate embryos using a stable episomal vector. Mol. Reprod. Dev., 62, 69-73.
149. Mazda, O. (2002) Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors. Curr. Gene Ther., 2, 379-392.
150. Lee, C.G., Vieira,W.D., Pastan, I. and Gottesman, M.M. (2001) An episomally maintained MDR1 gene for gene therapy. Hum. Gene Ther., 12, 945-953.
151. Mei, W.H., Qian, G.X., Zhang, X.Q., Zhang, P. and Lu, J. (2006) Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation. Haemophilia, 12, 271-279.
152. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
153. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
154. Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G., et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol., 26, 1276-1284.
155. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T. andYamanaka, S. (2008) Generation of pluripotent stemcells from adult mouse liver and stomach cells. Science, 321, 699-702.
156. Esteban, M.A., Xu, J., Yang, J., Peng, M., Qin, D., Li, W., Jiang, Z., Chen, J., Deng, K., Zhong, M., et al. (2009) Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J. Biol. Chem., 284, 17634-17640.
157. Liu, H., Zhu, F., Yong, J., Zhang, P., Hou, P., Li, H., Jiang,W., Cai, J., Liu, M., Cui, K., et al. (2008) Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell, 3, 587-590.
158. Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G.C., Kim, K., Miller, J.D., Ng, K. and Daley, G.Q. (2009) Generation of induced pluripotent stem cells from human blood. Blood, 113, 5476-5479.
159. Shimada, H., Nakada, A., Hashimoto, Y., Shigeno, K., Shionoya, Y. and Nakamura, T. (2010) Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol. Reprod. Dev., 77, 2.
160. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T., et al. (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. USA, 106, 15720-15725.
161. Takahashi, K. andYamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
162. Liao, J.,Wu, Z.,Wang, Y., Cheng, L., Cui, C., Gao, Y., Chen, T., Rao, L., Chen, S., Jia, N., et al. (2008) Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res., 18, 600-603.
163. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, II and Thomson, J. A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
164. Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T.W. and Smith, A. (2008) Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol., 6, e253.
165. Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H. and Hochedlinger, K. (2009) Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet., 41, 968-976.
166. Brambrink, T., Foreman, R.,Welstead, G.G., Lengner, C.J.,Wernig, M., Suh, H. and Jaenisch, R. (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell, 2, 151-159.
167. Okita, K., Ichisaka, T. and Yamanaka, S. (2007) Generation of germlinecompetent induced pluripotent stem cells. Nature, 448, 313-317.
168. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. and Hasegawa, M. (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNAvirus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 85, 348-362.
169. Jia, F., Wilson, K.D., Sun, N., Gupta, D.M., Huang, M., Li, Z., Panetta, N.J., Chen, Z.Y., Robbins, R.C., Kay, M.A., et al. (2010) Anonviral minicircle vector for deriving human iPS cells. Nat. Methods, 7, 197-199.
170. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P. and Woltjen, K. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771-775.
171. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. and Yamanaka, S. (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949-953.
172. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. and Hochedlinger, K. (2008) Induced pluripotent stemcells generated without viral integration. Science, 322, 945-949.
173. Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., Hamalainen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458, 766-770.
174. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu,Y., et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384.
175. Leight, E.R. and Sugden, B. (2001) Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol. Cell Biol., 21, 4149-4161.
176. Nanbo, A., Sugden, A. and Sugden, B. (2007) The coupling of synthesis and partitioning of EBVs plasmid replicon is revealed in live cells. EMBO J., 26, 4252-4262.
177. Mali, P.,Ye, Z.,Hommond, H.H.,Yu, X., Lin, J., Chen, G., Zou, J. and Cheng, L. (2008) Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells, 26, 1998-2005.
178. Rajala, K., Lindroos, B., Hussein, S.M., Lappalainen, R.S., Pekkanen-Mattila, M., Inzunza, J., Rozell, B., Miettinen, S., Narkilahti, S.,Kerkela, E., et al. (2010) A defined and xeno-free culture method enabling the establishment of clinicalgrade human embryonic, induced pluripotent and adipose stem cells. PLoS One, 5, e10246.
179. Totonchi, M., Taei, A., Seifinejad, A., Tabebordbar, M., Rassouli, H., Farrokhi, A., Gourabi, H., Aghdami, N., Hosseini-Salekdeh, G. and Baharvand, H. (2010) Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. Int. J. Dev. Biol., 54, 877-886.
180. Kameda, T., Smuga-Otto, K. and Thomson, J.A. (2006) A severe de novo methylation of episomal vectors by human ES cells. Biochem. Biophys. Res. Commun., 349, 1269-1277.
181. Ichida, J.K., Blanchard, J., Lam, K., Son, E.Y., Chung, J.E., Egli, D., Loh, K.M., Carter, A.C., Di Giorgio, F.P., Koszka, K., et al. (2009) A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 5, 491-503.
182. Maherali, N. and Hochedlinger, K. (2009) Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol., 19, 1718-1723.
183. Huangfu, D., Maehr, R., Guo,W., Eijkelenboom, A., Snitow, M., Chen, A.E. and Melton, D.A. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 26, 795-797.
184. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W. and Melton, D.A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 26, 1269-1275.
185. Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B.E., Jaenisch, R., Lander, E.S. and Meissner, A. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature, 454, 49-55.
186. Chen, Z.Y., He, C.Y., Meuse, L. and Kay, M.A. (2004) Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther., 11, 856-864.
187. Haase, R., Argyros, O., Wong, S.P., Harbottle, R.P., Lipps, H.J., Ogris, M., Magnusson, T., Pinto, M.G., Haas, J. and Baiker, A. (2010) pEPito: a significantly improved non-viral episomal expression vector for mammalian cells. BMC Biotechnol., 10, 20.
188. Mayrhofer, P., Blaesen, M., Schleef, M. and Jechlinger, W. (2008) Minicircle- DNA production by site specific recombination and protein-DNA interaction chromatography. J. Gene Med. 10, 1253-1269.
189. Wang, S. and Vos, J.M. (1996) A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol., 70, 8422-8430.